Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Lab - Quaterly Results

Date: 30-01-2024
A fair growth of 5.27% in the revenue at Rs. 41030.00 millions was reported in the December 2023 quarter as compared to Rs. 38976.00 millions during year-ago period.An average growth of 46.40% was recorded for the quarter ended December 2023 to Rs. 4752.00  millions from Rs. 3246.00 millions.The company reported a good operating profit of 8839.00 millions compared to 7265.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 41030.00 38976.00 5.27 143790.00 124085.00 15.88 169625.00 144052.00 17.75
Other Income 2276.00 514.00 342.80 6843.00 5728.00 19.47 5913.00 4820.00 22.68
PBIDT 8839.00 7265.00 21.67 51974.00 36302.00 43.17 48061.00 30761.00 56.24
Interest 56.00 28.00 100.00 159.00 143.00 11.19 169.00 380.00 -55.53
PBDT 8783.00 7237.00 21.36 51815.00 36159.00 43.30 47892.00 30381.00 57.64
Depreciation 2464.00 2388.00 3.18 7294.00 6865.00 6.25 9232.00 8143.00 13.37
PBT 6319.00 4849.00 30.32 44521.00 29294.00 51.98 38660.00 22238.00 73.85
TAX 1567.00 1603.00 -2.25 11449.00 9890.00 15.76 12532.00 6006.00 108.66
Deferred Tax -2.00 -385.00 -99.48 533.00 3568.00 -85.06 3891.00 2080.00 87.07
PAT 4752.00 3246.00 46.40 33072.00 19404.00 70.44 26128.00 16232.00 60.97
Equity 834.00 833.00 0.12 834.00 833.00 0.12 833.00 832.00 0.12
PBIDTM(%) 21.54 18.64 15.57 36.15 29.26 23.55 28.33 21.35 32.69